Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 136

1.

[It is worth concentrating on prevention of complications. An example from diabetic care].

Tennvall GR, Rosenqvist U, Nilsson LG.

Lakartidningen. 1997 Aug 20;94(34):2817-21. Swedish. No abstract available.

PMID:
9303991
2.

[How Germany manages it's diabetic patients].

Einecke D.

MMW Fortschr Med. 1999 Oct 21;141(42):4-5. German. No abstract available.

PMID:
10912093
3.

European comparison of costs and quality in the prevention of secondary complications in Type 2 diabetes mellitus (2000-2001).

Gandjour A, Kleinschmit F, Lauterbach KW; INTERCARE International Investigators.

Diabet Med. 2002 Jul;19(7):594-601.

PMID:
12099964
4.

Cooperation between general practitioners and diabetologists and clinical audit improve the management of type 2 diabetic patients.

Varroud-Vial M, Mechaly P, Joannidis S, Chapiro O, Pichard S, Lebigot A, Moulonguet M, Attali C, Bayle A, BĂ©nier J, Charpentier G.

Diabetes Metab. 1999 Mar;25(1):55-63.

PMID:
10335424
5.

The Diabetes Control and Complications Trial: new challenges for the primary physician.

Clarke WL.

Va Med Q. 1994 Summer;121(3):185-8. No abstract available.

PMID:
8061070
6.
7.

Standards of care for diabetes.

Weir GC, Nathan DM, Singer DE.

Diabetes Care. 1994 Dec;17(12):1514-22. Review. No abstract available.

PMID:
7882829
8.

Direct medical costs of complications resulting from type 2 diabetes in the U.S.

O'Brien JA, Shomphe LA, Kavanagh PL, Raggio G, Caro JJ.

Diabetes Care. 1998 Jul;21(7):1122-8.

PMID:
9653606
9.

The effects of treatment on the direct costs of diabetes.

Herman WH, Eastman RC.

Diabetes Care. 1998 Dec;21 Suppl 3:C19-24.

PMID:
9850482
10.

Cost of managing complications resulting from type 2 diabetes mellitus in Canada.

O'Brien JA, Patrick AR, Caro JJ.

BMC Health Serv Res. 2003 Mar 21;3(1):7.

11.

[Economic costs of diabetes mellitus: critical review and cost-benefit evaluation of proposed strategies for its reduction].

Rubio JA, Alvarez J.

Aten Primaria. 1998 Sep 15;22(4):239-55. Spanish. No abstract available.

PMID:
9803577
12.

Health economic considerations in the management of type 2 diabetes.

Clouse JC, Zitter M, Herman ME.

Manag Care Interface. 2002 Jan;15(1):66-71. Review.

PMID:
11828608
13.

Cost-effectiveness of glycemic control and ophthalmological care in diabetic retinopathy.

Polak BC, Crijns H, Casparie AF, Niessen LW.

Health Policy. 2003 Apr;64(1):89-97.

PMID:
12644331
14.

Assessing the impact of complications on the costs of Type II diabetes.

Williams R, Van Gaal L, Lucioni C; CODE-2 Advisory Board.

Diabetologia. 2002 Jul;45(7):S13-7. Epub 2002 Jun 12.

PMID:
12136406
15.

3: Preventing complications of diabetes.

Bate KL, Jerums G.

Med J Aust. 2003 Nov 3;179(9):498-503. Review.

PMID:
14583083
16.

The costs of treating long-term diabetic complications in a developing country: a study from India.

Kumpatla S, Kothandan H, Tharkar S, Viswanathan V.

J Assoc Physicians India. 2013 Feb;61(2):102-9.

PMID:
24471248
17.

An economic analysis of interventions for diabetes.

Klonoff DC, Schwartz DM.

Diabetes Care. 2000 Mar;23(3):390-404. Review.

19.

Diabetes nephropathy in the Netherlands: a cost effectiveness analysis of national clinical guidelines.

van Os N, Niessen LW, Bilo HJ, Casparie AF, van Hout BA.

Health Policy. 2000 Apr;51(3):135-47.

PMID:
10720684
20.

The economics of screening and treatment in type 2 diabetes mellitus.

Raikou M, McGuire A.

Pharmacoeconomics. 2003;21(8):543-64. Review.

PMID:
12751913

Supplemental Content

Support Center